CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, Inc.verified

CNSP

Price:

$6.86

Market Cap:

$3.94M

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of glioblastoma multiforme. It has license agreements with Houston Pharmaceuticals, Inc. and The University of Texas M.D. Anderson Cancer Center, as well as Animal Life Sciences, LLC; and a development agreement with WPD Pharmaceuticals Inc., as well as a collaboration agreement with Reata Pharmaceuticals, Inc. The company was incorporated in 2017 and is based in Houston, Texas...[Read more]

Industry

Biotechnology

IPO Date

2019-11-08

Stock Exchange

NASDAQ

Ticker

CNSP

The Enterprise Value as of May 2026 (TTM) for CNS Pharmaceuticals, Inc. (CNSP) is -2930824.00

According to CNS Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -2930824.00. This represents a change of -56.29% compared to the average of -6705195.37 of the last 4 quarters.

CNS Pharmaceuticals, Inc. (CNSP) Historical Enterprise Value (quarterly & annually)

How has CNSP Enterprise Value performed in the past?

The mean historical Enterprise Value of CNS Pharmaceuticals, Inc. over the last ten years is 25.31M. The current -2930824.00 Enterprise Value has changed -1257.96% with respect to the historical average. Over the past ten years (40 quarters), CNSP's Enterprise Value was at its highest in in the March 2019 quarter at 75.31M. The Enterprise Value was at its lowest in in the March 2025 quarter at -9128704.92.

Quarterly (TTM)
Annual

Average

25.31M

Median

13.89M

Minimum

-6377270.20

Maximum

75.21M

CNS Pharmaceuticals, Inc. (CNSP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of CNS Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 18.53%

Maximum Annual Enterprise Value = 75.21M

Minimum Annual Increase = -184.52%

Minimum Annual Enterprise Value = -6377270.20

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025-4544755.7518.53%
2024-3834245.28-184.52%
20234.54M-171.14%
2022-6377270.20-145.90%
202113.89M-13.06%
202015.98M-72.32%
201957.74M-23.23%
201875.21M0.03%

CNS Pharmaceuticals, Inc. (CNSP) Average Enterprise Value

How has CNSP Enterprise Value performed in the past?

The current Enterprise Value of CNS Pharmaceuticals, Inc. (CNSP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-1280784.53

5-year avg

734.88K

10-year avg

25.31M

CNS Pharmaceuticals, Inc. (CNSP) Enterprise Value vs. Peers

How is CNSP’s Enterprise Value compared to its peers?

CNS Pharmaceuticals, Inc.’s Enterprise Value is less than Windtree Therapeutics, Inc. (13.44M), greater than Pasithea Therapeutics Corp. (-48806317.00), less than NLS Pharmaceutics AG (-1600876.00), greater than Soligenix, Inc. (-4183187.00), less than Oragenics, Inc. (225.68M), less than 60 Degrees Pharmaceuticals, Inc. (5.78K), greater than Clearmind Medicine Inc. (-9168304.00), greater than Ensysce Biosciences, Inc. (-4003642274027.00), greater than GRI Bio, Inc. (-7952285.00), less than Silo Pharma, Inc. (-1335872.00),

CompanyEnterprise ValueMarket cap
13.44M$716.14K
-48806317.00$6.35M
-1600876.00$919.60K
-4183187.00$3.39M
225.68M$2.73M
5.78K$1.36M
-9168304.00$75.86K
-4003642274027.00$3.73M
-7952285.00$205.72K
-1335872.00$3.41M

Build a custom stock screener for CNS Pharmaceuticals, Inc. (CNSP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CNS Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CNS Pharmaceuticals, Inc. (CNSP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CNS Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is CNS Pharmaceuticals, Inc.'s Enterprise Value?

What is the highest Enterprise Value for CNS Pharmaceuticals, Inc. (CNSP)?

What is the 3-year average Enterprise Value for CNS Pharmaceuticals, Inc. (CNSP)?

What is the 5-year average Enterprise Value for CNS Pharmaceuticals, Inc. (CNSP)?

How does the current Enterprise Value for CNS Pharmaceuticals, Inc. (CNSP) compare to its historical average?